Form 4: Serina Therapeutics Director Gregory Bailey Buys Shares

Director Gregory Bailey of Serina Therapeutics, Inc. (SER) purchased 1,137 shares of common stock at an average price of $6.0259 on September 20, 2024.

Summary

• On September 20, 2024, Gregory Bailey, a director of Serina Therapeutics, Inc. (SER), acquired 1,137 shares of common stock.
• The purchase was made at a weighted average price of $6.0259 per share, with individual transactions ranging from $5.74 to $6.25 per share.
• Following the transaction, Bailey directly owns 63,377 shares of Serina Therapeutics.
• The transaction was reported on a Form 4 filing with the SEC on September 24, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares suggests confidence, but the scale of the purchase is not significant enough to warrant a higher score.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into a company's prospects. Purchases by directors are often viewed more favorably than sales.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates